10 April 2006
Atypical compound nevus arising in mature cystic ovarian teratoma.
Jonathan B. McHugh, Douglas R. FullenMed Sci Monit 2006; 12(4): CS34-37 :: ID: 448921
Abstract
Background: Mature cystic ovarian teratoma (MCOT) is the most common primaryovarian tumor. Rarely, MCOT may undergo malignant transformation. Melanoma arising primarily in MCOTis a rare event. Melanocytic nevi have also rarely been reported in MCOT. Case Report: A 28 year-oldfemale presented with a palpable, 4.6 cm, right pelvic mass on physical examination. Histologically,the cystic neoplasm demonstrated epidermis with numerous pilosebaceous units and respiratory-type epithelium(endoderm) surrounded by adipose tissue and cartilage (mesoderm). A 2.0x1.0 cm pigmented area correspondedto a nevus with architectural and cytologic features of the so-called "dysplastic nevus," including variable-sizednests of nevomelanocytes irregularly distributed on distorted rete ridges, bridging of nests betweenrete ridges, fibroplasia around rete ridges, and junctional shouldering beyond the dermal nevus. Thenevomelanocytes demonstrated moderate cytologic atypia. Diagnostic criteria of melanoma were not identified.Conclusions: Herein, we report, to the best of our knowledge, the first case of an atypical ("dysplastic")nevus, arising in a MCOT. No features of melanoma were present and the patient is disease-free at one-yearfollow-up. Rarely, melanocytic nevi and melanomas arise from the ectodermal component of MCOTs. Moreover,melanomas may arise de novo or in association with a nevus. Distinction between a melanocytic nevus,as in our case, and a primary melanoma is critical for determining the patient's prognosis and need foradditional therapy. As primary ovarian melanomas, like their skin counterpart, may arise from a precursorlesion, removal of a melanocytic nevus, such as this atypical nevus, could theoretically prevent melanomatransformation.
Keywords: Neoplasms, Multiple Primary - pathology, Nevus, Pigmented - pathology, Ovarian Neoplasms - pathology, Teratoma - pathology
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952